Thanks to Juristat examiner analytics, patent practitioners can now leverage data to shape prosecution strategy based on the decision history of an assigned examiner.

Here are  three essential (and often overlooked) examiner analytics that can lead to a more strategic prosecution.

Sprint and T-Mobile recently announced that they had reached a deal to merge, promising to “be a force for positive change in the U.S. wireless, video, and broadband industries.” Combining the country’s third and fourth largest mobile service providers would be one of the most significant consolidations in the American wireless market in years.

Two of the biggest pharmaceutical companies are joining forces in a blockbuster merger. Bristol-Myers Squibb is buying Celgene in a cash and stock deal valued at about $74 billion.

On Sunday, February 24, film fans, pop culture fanatics, and all of Hollywood’s brightest stars will tune in to the live broadcast of the 91st Oscars ceremony. With eight movies nominated for best picture, from the bombastic Queen biopic Bohemian Rhapsody to the devastatingly poetic Roma, the ceremony is guaranteed to be star-studded, ornate, and maybe even a little unpredictable.

As more and more of our daily life becomes automated, analyzed, and interconnected, people look forward to the Consumer Electronics Show (CES) every year to learn about emerging tech and its potential application to everyday life.

If you were following patent and innovation news in 2018, it was hard to avoid mentions of 3D printing.

IBM recently took a giant step forward to position itself as a leader in the new frontier of cloud computing.

All companies applying for patents need to stay up to date on competitor activity that may threaten the viability of their patent applications.

Juristat Platform consolidates Public PAIR information to help companies identify and monitor pending competitor applications for new developments.

Learn how to narrow your search to competitor applications in relevant tech areas and create a saved filter to regularly return for future review.

With 15 consecutive years on the Fortune 500 list, Monsanto has had a huge impact on innovation in modern farming and biotech. As a patent analytics company, we were curious to see how Bayer's recent acquisition of Monsanto impacts their IP portfolio.